Senior Manager, Global Late-Stage Partnering (Business Development)

Ipsen•Cambridge, MA

1d•$112,500 - $165,000

About The Position

The Senior Manager, Global Late-Stage Partnering is a member of Ipsen’s Global Late-Stage Partnering team and reports directly to the Vice President, Head of Late-Stage Partnering. The role leads and maintains Ipsen’s Late-Stage Opportunity Intelligence process across Oncology, Rare Diseases, and Neuroscience, developing a comprehensive view of the external partnering landscape and identifying and prioritizing potential business development opportunities. It coordinates cross-functional insights from R&D, Medical Affairs, Commercial, Finance, and Legal to assess the strategic fit and attractiveness of external programs and companies. The Senior Manager translates scientific, clinical, commercial, and competitive information into actionable insights, strategic analyses, and executive-level recommendations for portfolio planning and partnering decisions. The role also provides support on selected late-stage business development transactions, including opportunity evaluation and transaction execution, while primarily focusing on opportunity intelligence, landscape management, and strategic business development support.

Requirements

3–7 years of experience in business development, competitive intelligence, corporate strategy, management consulting, equity research, portfolio strategy, or the biopharmaceutical industry.
Bachelor’s or Master’s degree in a scientific, medical, or business discipline.
Strong understanding of the pharmaceutical and biotechnology industry, including drug development, regulatory pathways, commercialization, and business development.
Ability to evaluate scientific, clinical, commercial, competitive, and strategic dimensions of external opportunities.
Excellent analytical and critical-thinking skills, including the ability to synthesize large volumes of information into clear, actionable insights.
Strong attention to detail while maintaining a strategic, enterprise-wide perspective.
Ability to identify emerging trends and anticipate events that could influence partnering strategy and priorities.
Ability to work effectively in cross-functional environments and manage multiple priorities simultaneously.
Ability to establish credibility and work effectively with stakeholders across multiple functions and organizational levels.
Strong interpersonal and relationship-building skills.
Excellent written and verbal communication skills.
Ability to coordinate cross-functional input and drive alignment around opportunity assessments and recommendations.
Ability to communicate complex information effectively to senior executives and governance bodies.
Strong executive communication and presentation development skills, including preparation of Board-level materials.
Ability to influence without direct authority and operate effectively in a highly matrixed global organization.

Nice To Haves

Experience evaluating external assets, technologies, or pipeline opportunities is highly desirable.
Advanced scientific degree (PhD, PharmD, or MD) and/or MBA.

Responsibilities

Own and maintain a continuously updated landscape of late-stage partnering opportunities across Oncology, Rare Diseases, and Neuroscience.
Develop and manage a systematic process for identifying, tracking, evaluating, and prioritizing external assets and companies of strategic interest.
Monitor the external environment for emerging opportunities, competitive developments, strategic transactions, and market changes that may affect Ipsen’s business development priorities.
Establish and maintain tools, databases, dashboards, and reporting mechanisms to provide visibility into the external opportunity universe.
Serve as the internal owner of the external opportunity universe and ensure opportunity assessments remain current, organized, and actionable.
Track and analyze clinical, regulatory, commercial, corporate, and financing milestones for programs and companies of strategic interest.
Proactively communicate important developments and their potential implications to the Global Late-Stage Partnering team and relevant internal stakeholders.
Build and maintain working relationships with leaders and subject matter experts across Oncology, Rare Diseases, and Neuroscience.
Coordinate the gathering, consolidation, and maintenance of Ipsen’s perspectives on externally monitored assets and companies.
Maintain institutional knowledge of previous opportunity evaluations and strategic discussions.
Support selected late-stage business development transactions through opportunity assessments, diligence preparation, competitive analyses, valuation support, and internal decision-making materials.
Participate in transaction teams as appropriate, supporting the evaluation and execution of strategic licensing, acquisition, and collaboration opportunities.